Objectives: Pulmonary rehabilitation (PR) improves exercise capacity and health-related quality of life (HRQoL), and reduces health care utilisation. This study quantified outcomes of a PR program over a 6-year period and determined the effects of PR on hospitalisation.
Results: 187 (73%) of the 256 patients who entered PR completed the program. Improveme n t s i n 6 M W D ( 4 0 4 . 2 ± 1 1 4 . 6 m t o 43 9 .6 ± 11 5 .0 m, P < 0. 00 1 ) a n d H R Q o L (4.1 ±0.9 points per item to 4.9 ±0.9 points per item, P < 0.001) occurred following PR. There was a 46% reduction in the number of patients admitted to hospital (71 to 38) with a COPD exacerbation and a 62% reduction in total bed-days (1131 to 432) following PR. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) represents a significant economic burden in terms of health care cost. Hospitalisation due to exacerbation is consistently the greatest cost component of COPD care. [1] [2] [3] Pulmonary rehabilitation (PR) is an effective management strategy for patients with COPD and has been shown to reduce symptoms and increase exercise capacity and health-related quality of life (HRQoL). 4, 5 There is also evidence from randomised controlled trials, 6 ,7 a systematic review 8 and clinical reports [9] [10] [11] [12] [13] that PR reduces health care utilisation in COPD. Economic evaluations of PR programs have shown that the resulting reduction in health care utilisation is likely to more than offset the cost outlay in providing such programs.
Conclusion

Rehabilitation, Disability and Ageing
Data collected by the Australian Lung Foundation before 2000 revealed that fewer than 1% of patients with COPD in Australia were receiving PR. 16 Guidelines for the management of COPD in Australia and New Zealand were developed (COPD-X), and access to PR is strongly recommended for patients with moderate to severe disease. 5 In response to these guidelines, more PR programs have been established across Australia in both hospital and community settings. To date, outcomes from PR programs conducted in Australia over an extended period of time have not been published.
The main aim of this study was to quantify outcomes of a PR program provided at a teaching hospital within Australia. The secondary aim was to determine whether completion of the program was associated with a reduction in hospital admissions and length of stay for COPD exacerbations as has been reported following programs carried out in other countries. [6] [7] [8] [10] [11] [12] [13] 
Methods
Patients
All patients with a medical diagnosis of COPD (post-bronchodilator FEV 1 < 80%, FEV 1 / FVC < 70%) who entered a PR program at a university teaching hospital (Sir Charles Gairdner Hospital [SCGH] Perth, Western Australia) over a 6-year period (1998 to 2003) entered the study. Referrals to the program were predominantly from outpatient respiratory clinics and private physicians. Patients with dyspnoea on physical activity despite optimal medical management were suitable for referral and were admitted to the program when their respiratory condition was stable and there had been no changes in their medication in the preceding 4 weeks. To be included in the program, individuals must have an absence of severe musculoskeletal impairment or uncontrolled cardiovascular disease, and a 6-minute walk dista nce (6M WD) > 20 0m. P atients with a 6MWD < 200m have been shown to experience difficulties completing the program due to the physical separation (140m) of the walking track and the gymnasium used for exercise training.
These patients are offered home-based rehabilitation and were not included in this study. We also excluded patients if they had undergone lung volume reduction surgery or work-up for lung transplantation.
Formal approval for undertaking this analysis was granted by the Human Research Ethics Committee of SCGH.
The pulmonary rehabilitation program
This was a continuous rolling program with each patient attending two exercise classes (75 minutes duration) each week for a period of 8 weeks. Exercise classes consisted of six to 10 patients supervised by a physiotherapist (N C or S C J). Exercise training comprised a 20-minute walking program within an enclosed hospital corridor, flexibility and stretching exercises, and a sixstation exercise circuit in a gymnasium. The 20-minute high-intensity walking program was initially prescribed at an intensity equivalent to 80% of the average walking speed achieved on the pre-PR 6-minute walk test (6MWT). [17] [18] [19] The circuit comprised unsupported upper limb exercises and lower limb exercises aimed at improving muscle strength and endurance. Simple equipment was used to allow easy replication of the exercises in the home environment. The modalities of exercise used in the exercise circuit were based on responses to the dyspnoea domain of the Chronic Respiratory Disease Questionnaire (CRDQ), 20 with exercises selected for the individual with the aim of training the muscle groups involved in the activities of daily living that provoked dyspnoea. Intensity, frequency and duration of the circuit exercises were prescribed in accordance with recommendations in the Pulmonary Rehabilitation Toolkit. 17 Patients prescribed long-term oxygen therapy and those who showed marked desaturation with activity used supplemental oxygen during exercise in accordance with national guidelines. 21 The exercise intensity or duration of each exercise was increased weekly within symptom tolerance. 19 In addition to the supervised classes, patients were instructed to complete a home exercise program on an additional 2 or 3 days each week.
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Informal education sessions took place during the rest period (about 15 minutes) between the walking program and the exercise circuit. These sessions encouraged problem-solving and positive self-management behaviours. Topics included managing breathlessness, action plans for COPD exacerbations, maintaining regular exercise, communicating with health professionals, and oxygen therapy. A formal education session was offered to participants and their support person or carer on three occasions each year. A doctor, physiotherapist and pharmacist covered topics such as "How the lungs work in health and disease", "Respiratory conditions and their management" and "Medications and correct inhaler technique". Where necessary, patients were referred for nutritional advice or smoking cessation counselling. All participants were given information on local patient support groups.
At the conclusion of the 8-week program, patients were encouraged to join a communitybased maintenance exercise class supervised by a physiotherapist and to continue with their home exercise program. A small number of patients (average of five each year) with severe disease and multiple comorbid conditions were offered a hospital-based maintenance exercise class.
Assessment
Before commencing PR, anthropometric data, smoking history and spirometric data were obtained. Before and immediately following the 8-week program, functional exercise capacity and HRQoL were measured.
Functional exercise capacity
The 6MWT was used to measure functional exercise capacity. The test was performed in accordance with current recommendations but modified to include standardisation of the frequency of encouragement given to patients who rested during the test and the measurement of oxygen saturation and heart rate during the test. 17, 22 All tests were supervised by a physiotherapist (N C or S C J).
The 6MWT was performed over a 45m straight course within a level, enclosed corridor. Before each test standardised instructions were read aloud to the patient. 17 Each minute patients were informed of the number of minutes remaining and were given standardised encouragement. In the event that a patient rested during the test, encouragement to recommence walking was given at 15 second intervals. The 6MWT was performed twice at baseline (pre-PR) assessment, with a 20-30 minute rest period separating the two tests, and the greatest distance was recorded. A single 6MWT was performed at the post-PR assessment.
Health-related quality of life
The CRDQ, using the interview format with informed responses at post-PR assessment, was used to measure HRQoL. 20, 23 This questionnaire quantifies the four domains of: dyspnoea, fatigue, emotional function and mastery.
Hospitalisation
The number of hospital admissions for a COPD exacerbation and total bed-days (calculated by adding bed-days from all admissions) in the 12-month period before PR and the 12-month period following PR were recorded. Data were collected by patient report and verified by searching hospital databases for patients' admissions to hospital for a COPD exacerbation and the days spent in hospital. Patients who completed PR but died in the 12 months following the program were excluded from this analysis.
Statistical analysis
Distribution of the data was examined and data were transformed for statistical analyses where necessary. The 6MWD and CRDQ data pre-and post-PR were compared using paired t-tests. Unpaired t-tests were used to compare baseline data on patients who completed and those who did not complete PR, and the magnitude of change between the men and women who completed the program. The number of hospital admissions before and after the program were compared using unpaired t-tests (continuous variables) and χ 2 tests (discrete variables). The numbers of patients admitted to hospital before and Rehabilitation, Disability and Ageing after the program were compared using the proportions admitted. Analyses were performed using SPSS, Version 11 (SPSS Inc, Chicago, Ill, USA). An alpha value of р 0.05 was considered to be significant. Data are presented as mean ± SD unless otherwise stated.
Results
Two hundred and fifty-six patients with COPD who entered PR over the 6-year period were included in this study. Twenty-nine patients were excluded, as they had undergone lung volume reduction surgery or work-up for lung transplantation. Patients were considered to have completed the program if they attended at least 10 exercise classes (ie, at least 60% of their scheduled classes) and completed the reassessment. One hundred and eighty-seven patients (73%) completed PR. Reasons for non-completion were mostly due to medical problems, COPD and non-COPD related, and other issues including transport difficulties, relocation and poor attendance. Forty-five (24%) of the program graduates attended formal education sessions. At the completion of the program, 42% of the graduates commenced a maintenance exercise program either at the hospital (17%) or in the community (25%).
Box 1 shows the baseline characteristics of the 187 patients who completed the program. The majority of patients (85%) had moderate or severe COPD. 5 The 69 patients who did not complete PR had a lower FEV 1 Rehabilitation, Disability and Ageing body mass index for the patients who did not complete was also lower, however this did not reach s ign ifican ce (23.4 ± 0 .5 k g/ m 2 v 25.0 ±0.5 kg/m 2 , P = 0.12).
Functional exercise capacity and HRQoL
Box 2 shows the 6MWD and CRDQ data for the patients who completed PR. The CRDQ data are not reported for 44 patients who experienced difficulties completing the questionnaire due to visual impairment or language problems. Improvements in 6MWD (P < 0.001) and all domains of the CRDQ (P < 0.001) were found following PR. The magnitude of improvement in each domain of the CRDQ exceeded the minimum clinically important difference. 25 The magnitude of change in 6MWD and each domain of the CRDQ were similar in men and women (P > 0.05).
COPD-related hospitalisations for patients completing PR
In the 12 months following PR, 10 of the 187 patients (6%) who completed the program died and were excluded from further analysis. Box 3 shows the number of admissions for COPD exacerbations and total bed-days for the remaining 177 patients in the 12 months before and following PR. Seventy-one patients had at least one COPD-related admission in the 12 months before PR and 38 patients had an admission in the 12 months following PR. This represents a 46% reduction in the number of patients admitted to hospital for a COPD exacerbation and a 51% reduction in total hospital admissions (127 to 61) following PR. There was a 62% reduction (1131 to 432 days) in the total bed-days in the 12 months following PR. Although there was a strong trend towards a decrease in the average length of stay for admissions following PR compared with pre PR (11.1 ±15.0 to 7.3 ±4.7 days), this did not reach statistical significance.
The average per-day cost for a COPD admission was A$568 26 (corrected by a health index deflator to reflect 2003 cost 27 ). Based on this figure, hospitalisation costs for COPD exacerbations in the 12 months before and following PR were A$642 408 and A$245 376 respectively (Box 3). This represents a net saving of A$397 032 in hospitalisation costs in the 12 months following PR.
Of the 71 patients who were admitted to hospital in the 12 months before PR, 28 patients (40%) had an admission for a COPD exacerbation in the 12 months following PR. Eight patients who did not have an admission in the 12 months before PR were admitted in the 12 months following PR for a COPD exacerbation. Twenty eight patients had two or more admissions (total of 95 admissions) in the 12 months before PR. Of these 28 patients, 13 had no admissions, 9 had one admission and 6 patients had two or more admissions (total of 35 admissions) in the 12 months following PR.
Discussion
To our knowledge, this is the first reported study of outcomes and hospitalisation data following PR in an Australian cohort of COPD patients over an extended period of time (6 years Rehabilitation, Disability and Ageing show our PR program improves functional exercise capacity and HRQoL in the short-term, and is associated with a reduction in hospitalisation for COPD exacerbations in the 12 months following rehabilitation. Of the patients entering PR, 73% completed the program. This high attrition rate is similar to that reported by others.
9,28
Hospitalisation Following PR, the reduction in total bed-days was due to a decrease in the number of patients being admitted to hospital and a reduction in the length of stay. This differs to the findings of a study carried out in the United Kingdom 6 that reported an overall reduction in days spent in hospital following PR due to a decrease in the frequency and duration of admissions but not the number of patients admitted. Although there is a historic decline in average length of stay in public acute hospitals within Australia, during the 6-year period of this analysis the average length of stay in public acute hospitals did not vary. 29 There is some evidence of a trend towards a decline in length of stay for COPD admissions during the period of the study, however, this does not account for the change observed following the PR intervention.
30
Costs
The reduction in hospitalisation related to COPD exacerbations following our PR program would result in significant savings to the health care system. The cost of our PR program was A$292 (2003) per patient based on previously reported data 31 and corrected using a health index deflator. 27 The inclusion of equipment and overhead costs (an additional 25% consistent with Griffiths et al 14 ) gives rise to an overall program cost of A$93 440 for 256 patients. This figure is modest and compares favourably with the costs of programs in the UK 28 and in Canada. 15 The reduction in hospitalisation in the 12 months following PR resulted in a net saving of A$397 032 (Box 3). Hence the cost of providing PR at SCGH to the 256 patients who entered over the 6-year period represents only 23% of the total savings from the subsequent reduction in bed-days. These findings are consistent with studies undertaken elsewhere. Evidence of cost-effectiveness of PR in the UK has been reported. Griffiths and colleagues 14 performed a cost/utility analysis in conjunction with their randomised-controlled trial of PR versus standard care. 6 This comprehensive analysis included quality-adjusted life years, direct and indirect costs. Their findings showed that the savings from the downstream reduction in health care utilisation more than offset the cost of providing PR, and thus PR resulted in financial benefits to the health service. An economic evaluation of community-based PR in Canada reported a reduction of total costs of C$344 per person per year. 15 Regardless of COPD severity, PR was associated with decreased health care utilisation, reduced direct costs and improved health status. The magnitude of the cost savings following PR in Australia that arise due to a reduction in hospitalisation for COPD exacerbations is similar to that reported following PR in other countries. 14, 15 Further, these savings far outweigh the cost of providing such a program.
Factors affecting hospitalisation
The increased levels of physical activity promoted in our PR program possibly contributed to the reduction in hospitalisation. Garcia-Aymerich et al 32 showed that patients with COPD who reported high levels of physical activity (equivalent to greater that 60 minutes of walking per day) had a 46% reduction in hospital readmission for COPD. Our program has a large component of walking and emphasises the importance of walking in functional activities. Functional exercise capacity, as measured by the 6MWD, is a strong correlate of walking and standing time during daily life in COPD patients 33 and a 6MWD of less than 367m has been reported to increase the risk of hospitalisation in this population. 34 Before PR, 43% of our patients achieved a 6MWD of less than 367m, and this decreased to 26% of patients following PR. This improvement in 6MWD may have reduced the risk of hospitalisation and contributed to the decrease in the number of patients admitted to hospital for an exacerbation of COPD.
Rehabilitation, Disability and Ageing
The improvements in HRQoL following our program may also have contributed to the reduction in hospitalisation. Patients with COPD who have poor HRQoL have been shown to be at greater risk of hospital readmission. 35 In particular, improvements in the mastery domain of the CRDQ following our program may reflect improved coping strategies that in turn may have contributed to the patient' s confidence in managing an exacerbation. In a study of the effects of early treatment on COPD exacerbations, patients who did not seek early treatment were more likely to be hospitalised for the management of an exacerbation and had poorer HRQoL. 36 Education sessions in our program, both formal and informal, may have contributed to the reduction in hospitalisation as a result of improved adherence with medications and oxygen therapy and earlier recognition and management of exacerbations.
Limitations
The main limitation of this study is the lack of a randomised control group, and thus we are unable to account for confounding factors such as changes in medications in the 12 months following PR, the impact of influenza epidemics or improvements in general practice and management during hospital admissions. To the best of the authors' knowledge, no structured programs aimed at improving inpatient management of COPD were implemented during the period of the study. However, for this group of patients there was a reduction in hospitalisation compared with the previous 12 months and this is consistent with the findings of randomised-controlled trials. 6, 7 Finally, these findings are not able to be generalised to patients with severe functional limitation (6MWD < 200 m) as they were not included in the study due to their inability to manage an outpatient program in this setting.
Conclusion
This study suggests that an outpatient PR program conducted in Australia results in significant improvements in functional exercise capacity and HRQoL, and a reduction in hospitalisation due to COPD exacerbations. The savings incurred from the reduction in hospitalisation far outweigh the costs of providing such a program.
